{
    "2021-05-19": [
        [
            {
                "time": "",
                "original_text": "医药生物行业研究周报：建议以中期维度看医药行情",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "中期",
                        "行情"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "CXO2020年报及2021一季报总结：CXO向好 CDMO行业进入加速期",
                "features": {
                    "keywords": [
                        "CXO",
                        "CDMO",
                        "加速期",
                        "年报",
                        "季报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泡沫？国内CXO巨头营收仅为昆泰的1/4，市值却位列全球第一，凭什么？",
                "features": {
                    "keywords": [
                        "泡沫",
                        "CXO",
                        "营收",
                        "市值"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗板块继续走弱，医疗ETF今年以来份额增长近40亿份",
                "features": {
                    "keywords": [
                        "医疗",
                        "板块",
                        "走弱",
                        "ETF",
                        "份额增长"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【牛人重仓】药明康德:15日、30日、60日、120日融资余额增仓形成共振，今日资金流入-5557.75万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "融资余额",
                        "北向资金",
                        "主力资金",
                        "增仓"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【牛人重仓】药明康德:牛人重仓绩优股今年以来融资余额增仓100%以上，今日资金流入-1409.97万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "融资余额",
                        "北向资金",
                        "主力资金",
                        "增仓"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "明日下午3点！高通量和高内涵药物筛选——点亮新靶点的药物研发里程",
                "features": {
                    "keywords": [
                        "高通量",
                        "高内涵",
                        "药物筛选",
                        "新靶点",
                        "研发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}